2fmb

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "2fmb" [edit=sysop:move=sysop])
Current revision (06:44, 9 August 2023) (edit) (undo)
 
(7 intermediate revisions not shown.)
Line 1: Line 1:
-
[[Image:2fmb.png|left|200px]]
 
-
{{STRUCTURE_2fmb| PDB=2fmb | SCENE= }}
+
==EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130==
 +
<StructureSection load='2fmb' size='340' side='right'caption='[[2fmb]], [[Resolution|resolution]] 1.80&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[2fmb]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Equine_infectious_anemia_virus Equine infectious anemia virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FMB OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2FMB FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.8&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=LP1:4-[2-(2-ACETYLAMINO-3-NAPHTALEN-1-YL-PROPIONYLAMINO)-4-METHYL-PENTANOYLAMINO]-3-HYDROXY-6-METHYL-HEPTANOIC+ACID+[1-(1-CARBAMOYL-2-NAPHTHALEN-1-YL-ETHYLCARBAMOYL)-PROPYL]-AMIDE'>LP1</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2fmb FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2fmb OCA], [https://pdbe.org/2fmb PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2fmb RCSB], [https://www.ebi.ac.uk/pdbsum/2fmb PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2fmb ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/Q66729_9RETR Q66729_9RETR]
 +
== Evolutionary Conservation ==
 +
[[Image:Consurf_key_small.gif|200px|right]]
 +
Check<jmol>
 +
<jmolCheckbox>
 +
<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/fm/2fmb_consurf.spt"</scriptWhenChecked>
 +
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
 +
<text>to colour the structure by Evolutionary Conservation</text>
 +
</jmolCheckbox>
 +
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=2fmb ConSurf].
 +
<div style="clear:both"></div>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
One of the major problems encountered in antiviral therapy against AIDS is the emergence of viral variants that exhibit drug resistance. The sequences of proteases (PRs) from related retroviruses sometimes include, at structurally equivalent positions, amino acids identical to those found in drug-resistant forms of HIV-1 PR. The statine-based inhibitor LP-130 was found to be a universal, nanomolar-range inhibitor against all tested retroviral PRs. We solved the crystal structures of LP-130 in complex with retroviral PRs from HIV-1, feline immunodeficiency virus, and equine infectious anemia virus and compared the structures to determine the differences in the interactions between the inhibitor and the active-site residues of the enzymes. This comparison shows an extraordinary similarity in the binding modes of the inhibitor molecules. The only exceptions are the different conformations of naphthylalanine side chains at the P3/P3' positions, which might be responsible for the variation in the Ki values. These findings indicate that successful inhibition of different retroviral PRs by LP-130 is achieved because this compound can be accommodated without serious conformational differences, despite the variations in the type of residues forming the active-site region. Although strong, specific interactions between the ligand and the enzyme might improve the potency of the inhibitor, the absence of such interactions seems to favor the universality of the compound. Hence, the ability of potential anti-AIDS drugs to inhibit multiple retroviral PRs might indicate their likelihood of not eliciting drug resistance. These studies may also contribute to the development of a small-animal model for preclinical testing of antiviral compounds.
-
===EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130===
+
Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV.,Kervinen J, Lubkowski J, Zdanov A, Bhatt D, Dunn BM, Hui KY, Powell DJ, Kay J, Wlodawer A, Gustchina A Protein Sci. 1998 Nov;7(11):2314-23. PMID:9827997<ref>PMID:9827997</ref>
-
{{ABSTRACT_PUBMED_9827997}}
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
 
+
</div>
-
==About this Structure==
+
<div class="pdbe-citations 2fmb" style="background-color:#fffaf0;"></div>
-
[[2fmb]] is a 1 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Equine_infectious_anemia_virus Equine infectious anemia virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FMB OCA].
+
==See Also==
==See Also==
-
*[[Virus protease|Virus protease]]
+
*[[Virus protease 3D structures|Virus protease 3D structures]]
-
 
+
== References ==
-
==Reference==
+
<references/>
-
<ref group="xtra">PMID:009827997</ref><ref group="xtra">PMID:011152609</ref><references group="xtra"/>
+
__TOC__
 +
</StructureSection>
[[Category: Equine infectious anemia virus]]
[[Category: Equine infectious anemia virus]]
-
[[Category: HIV-1 retropepsin]]
+
[[Category: Large Structures]]
-
[[Category: Gustchina, A.]]
+
[[Category: Gustchina A]]
-
[[Category: Kervinen, J.]]
+
[[Category: Kervinen J]]
-
[[Category: Lubkowski, J.]]
+
[[Category: Lubkowski J]]
-
[[Category: Wlodawer, A.]]
+
[[Category: Wlodawer A]]
-
[[Category: Zdanov, A.]]
+
[[Category: Zdanov A]]
-
[[Category: Aspartic protease]]
+
-
[[Category: Eiav]]
+
-
[[Category: Horse]]
+
-
[[Category: Retropepsin]]
+
-
[[Category: Retrovirus]]
+

Current revision

EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130

PDB ID 2fmb

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools